Belonging to the ESC Young Community is being part of a family that will follow you throughout your career.
Network with professionals all around the world. Discover our education and grants offers.
Boost your career and your personal development by joining one of our groups today!
Covering the full spectrum of cardiology
Outstanding opportunities to advance your career. Application deadline 31 January 2018
Aged 35 and under ?
Submit your clinical case and compete for awards worth up to €2,000.
ESC Membership allows you to be part of a unique community at the forefront of cardiovascular medicine.
High quality plenary and keynote lectures by experts in cardiovascular pharmacotherapy as well as several activities dedicated to the CPPTs and the members of the ESC young communities.
Every year the Working Group on Cardiovascular Pharmacotherapy organises EuroCVP Meeting to gather pharmacologists, pharmacists, research nurses and personnel, as well as general cardiologists with an interest in cardiovascular pharmacotherapy, pharmacology and heart failure.
All cardiologists are concerned by pharmacology and drugs therapy, thus, they should all participate and contribute to EuroCVP.
During the meeting, focus is made on key treatment breakthroughs, clinical applicability and significance of new drugs and new data. Since 2015, a Clinical Trials Workshop is held in conjunction to the main conference to give a focused view of the clinical trial arena, including trial methodology, trial challenges, trial interpretation and analysis, regulatory issues and good clinical practice.
The ESC Working Group on Cardiovascular Pharmacotherapy is proud to be delivering an engaging and interactive 2 day course to improve the professional knowledge and skills required to plan and deliver successful cardiovascular pharmacotherapy clinical trials.
The European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy is proud to be delivering an engaging and interactive 2 day course to improve the professional knowledge and skills required to plan and deliver successful cardiovascular pharmacotherapy clinical trials.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved